University of Hawaiʻi Cancer Center researchers found in laboratory and animal models that when breast cancers stop ...

“These findings by our University of Hawai‘i Cancer Center research team show that drug resistance is not necessarily the end ...

Chemotherapy drugs that target cancer cells without damaging normal cells remain one of the key goals of precision medicine ...

For patients living with HER2-positive metastatic breast cancer, the recent FDA approval of trastuzumab deruxtecan (brand ...

Mapping how Narcan reverses opioid overdose can provide a molecular blueprint for developing more effective drugs against overdose.

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

This study investigates the molecular mechanisms underlying ligand recognition, subtype selectivity, and activation of ...

The Trump administration has lined up another country-specific trade agreement, this time with the U.K., which confers Washington’s biggest break on pharmaceutical import tariffs yet. For its part, ...

Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an ...

Reviva Pharmaceuticals Inc. (NASDAQ: RVPH), a late clinical stage pharmaceutical company aiming to revolutionize the schizophrenia treatment market with Brilaroxazine, its developmental drug, made ...

The decision is based on the recommendation from an Independent Data Monitoring Committee (IDMC) to stop the trials for futility following its review of data from a pre-specified interim analysis.